Immunostaining for the proliferation marker Ki67 revealed that, compared to vehicle treated tumors, BEZ235 single treatment resulted in significant reduction of PC3 and PC3-AR tumor proliferation (PC3, p<0.0001; PC3-AR, p=0.0007). The gene discussed is AR; the disease is neoplasm.